INTERNATIONAL PATENT: NEUMORA THERAPEUTICS, INC., CAMBREX, INC. FILES APPLICATION FOR "CRYSTALLINE FORMS OF 7-((2R,4S)-4-((2,3-DIHYDROBENZO[B][1,4] DIOXIN-6-YL-2,2,3,3-D4)OXY)-2-METHYLPIPERIDIN-1-YL)-8-METHYL-4H-PYRIMIDO[1,2-B]PYRIDAZIN -4-ONE"

GENEVA, June 19 -- NEUMORA THERAPEUTICS, INC. (490 Arsenal Way, Suite 200Watertown, Massachusetts 02472), CAMBREX, INC. (One Meadowlands PlazaEast Rutherford, New Jersey 07073) filed a patent application (PCT/US2024/058647) for "CRYSTALLINE FORMS OF 7-((2R,4S)-4-((2,3-DIHYDROBENZO[B][1,4] DIOXIN-6-YL-2,2,3,3-D4)OXY)-2-METHYLPIPERIDIN-1-YL)-8-METHYL-4H-PYRIMIDO[1,2-B]PYRIDAZIN -4-ONE" on Dec 05, 2024. With publication no. WO/2025/122733, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AKITI, Otute (490 Arsenal Way, Suite 2...